Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Tuoxin Pharmaceutical(301089) the Revenue is 118.8 M (+39.92%);the EBIT is -15.99 M (-12.75%);the EPS is -0.142 (-37.42%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.12B39.92%
----
----
EBIT
-0.02B12.75%
----
----
EPS
-0.142137.42%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf